VITAE PHARMACEUTICALS INC - COM (VTAE)

CUSIP: 92847N103

Q3 2014 13F Holders as of 30 Sep 2014

Type / Class
Equity / COM
Total 13F shares
5,897,088
Share change
+5,897,088
Total reported value
$44,994,000
Price per share
$7.63
Number of holders
15
Value change
+$44,994,000
Number of buys
15

Quarterly Holders Quick Answers

What is CUSIP 92847N103?
CUSIP 92847N103 identifies VTAE - VITAE PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of VITAE PHARMACEUTICALS INC - COM (VTAE) as of Q3 2014

As of 30 Sep 2014, VITAE PHARMACEUTICALS INC - COM (VTAE) was held by 15 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,897,088 shares. The largest 10 holders included NEA Management Company, LLC, MARXE AUSTIN W & GREENHOUSE DAVID M, BVF INC/IL, FMR LLC, WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST, Alyeska Investment Group, L.P., JPMORGAN CHASE & CO, INTEL CORP, MILLENNIUM MANAGEMENT LLC, and Marshall Wace LLP. This page lists 15 institutional shareholders reporting positions in this security for the Q3 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.